MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ekir.2026.106702

Медицинская библиотека · Kidney international reports · 2026

Urinary CXCL9 Across the Spectrum of Kidney Allograft Inflammation.

Cortes Garcia Esteban, Wellekens Karolien, Tinel Claire, Chhun Stéphanie, Debiais-Deschamps Charlotte, Leon Juliette, Troger Antoine, Roger Camille, Burger Carole, Le Stang Marie-Bénédicte, Lebraud Emilie, Peraldi Marie-Noelle, Legendre Christophe, Martinez Frank, Sberro-Soussan Rebecca, Zuber Julien, Rabant Marion, Terzi Fabiola, Essig Marie, Gwinner Wilfried, Marquet Pierre, Van Loon Elisabet, Naesens Maarten, Anglicheau Dany, Aubert Olivier

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Kidney allograft inflammation spans a heterogeneous spectrum of phenotypes defined by the Banff 2022 classification. We assessed whether urinary C-X-C motif chemokine ligand 9 (uCXCL9) normalized to creatinine (uCXCL9:Cr) captures inflammatory burden across this spectrum and provides incremental diagnostic utility beyond standard variables.

METHODS

We analyzed 3181 biopsy-urine pairs from a development cohort (1341 biopsies from 921 patients) and an independent external validation cohort (1840 biopsies from 917 patients). Associations with Banff 2022 diagnostic categories were evaluated using multinomial logistic regression with stability-based selection. Incremental performance was assessed using the Hand & Till multiclass area under the curve (AUC) and decision curve analysis.

RESULTS

uCXCL9:Cr demonstrated a graded increase across the inflammatory spectrum, with lowest levels in biopsies without specific lesions (median 4.55 ng/mmol), intermediate levels in antibody-mediated phenotypes (15.14), higher levels in acute T cell-mediated rejection (TCMR; 46.11), and the highest levels in mixed inflammatory patterns (53.18-134.05; P < 0.001). Levels increased proportionally with microvascular and tubulointerstitial activity scores (all P < 0.001). In multivariable multinomial analyses, uCXCL9:Cr was independently associated with each inflammatory category across the Banff 2022 spectrum (relative risk ratio [RRR] range: 1.68-3.44; all P ≤ 0.004). Addition of uCXCL9:Cr increased multiclass AUC from 0.797 to 0.831 in the development cohort and from 0.801 to 0.821 in the validation cohort (both P = 0.001). Incorporation of uCXCL9 was associated with a potential reduction in unnecessary biopsies in decision-curve analyses.

CONCLUSION

uCXCL9 reflects active kidney-graft inflammation across modern Banff phenotypes and provides clinically meaningful diagnostic information beyond standard variables, supporting its potential to inform biopsy decisions and monitoring in kidney transplant recipients, pending prospective validation.

Для цитирования: Cortes Garcia Esteban, Wellekens Karolien, Tinel Claire, Chhun Stéphanie, Debiais-Deschamps Charlotte, Leon Juliette, Troger Antoine, Roger Camille, Burger Carole, Le Stang Marie-Bénédicte, Lebraud Emilie, Peraldi Marie-Noelle, Legendre Christophe, Martinez Frank, Sberro-Soussan Rebecca, Zuber Julien, Rabant Marion, Terzi Fabiola, Essig Marie, Gwinner Wilfried, Marquet Pierre, Van Loon Elisabet, Naesens Maarten, Anglicheau Dany, Aubert Olivier. Urinary CXCL9 Across the Spectrum of Kidney Allograft Inflammation.. Kidney international reports. 2026. DOI: 10.1016/j.ekir.2026.106702.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.